Brochure | December 4, 2013

Clinical And Commercial Drug Substance (DS) And Drug Substance Intermediate (DSI) Production

Source: Pfizer CentreSource

Pfizer CenterSouces's Andover facility has extensive experience in biopharma manufacturing and operational science:

  • Strengths align with manufacture of a wide range of products –simple to complex, low volume to high volume
  • Access to contemporary, state-of-the-art technologies provides competitive advantage
  • Strong focus on operation sciences –flexible use of facilities and staff, responsiveness to changing product mix, constant drive to improve costs
  • Competitive cost structure
  • History of successful product escort through development, scale-up and launch
  • Knowledge of worldwide regulatory requirements and experience interacting with worldwide regulatory agencies is an additional strength
  • Agile and responsive Quality Control unit that operates under Lean Laboratories principles to maximize testing and personnel efficiency
  • Scientific staff with robust experience with standard analytical, bio-analytical, raw material and microbiological industry techniques

For full access to this content, please Register or Sign In.

Access Content Clinical And Commercial Drug Substance (DS) And Drug Substance Intermediate (DSI) Production